28 December 2007
Colchicine against ischemia-reperfusion injury in experimental lung transplantation
Jaroslaw Pieróg, Bartosz Kubisa, Tomasz Grodzki, Janusz Wójcik, Juliusz Pankowski, Justyna Ostrowska, Zygmunt Juzyszyn, Marek DroździkAnn Transplant 2007; 12(4): 32-37 :: ID: 764932
Abstract
Background: To asses the influence of colchicine, a potent antinflammatory agent and neutrophile migration inhibitor, on Ischemia-Reperfusion Injury (IRI) in rat lung isogeneic transplantation.
Material/Methods: Isogeneic, orthotropic single left lung transplantations were performed among male Wistar rats after total ischemic graft storage time of 12 or 18 hours in temperature of 4°C. Recipients received either no specific treatment (control) or Colchicine 1.2 mg/kg/d ip. Twenty-four hours after transplantation, the native contralateral lung was occluded to assess graft gas exchange function (PaO[sub]2[/sub]). The lung graft was excised and assessed for Wet/Dry ratio (W/D) as a measure of edema, Myeloperoxidase activity (MPO) as a measure of neutrophile migration and histology.
Results: PaO[sub]2[/sub] differences were not significant among all groups. Comparing colchicine to control group, the W/D ratio 3.93±0.66 vs. 1.86±0.32, p=0.002 and MPO 8.1±3.34 vs. 5.87±1.76, p=0.046 were significantly higher for 18 hours colchicine group.
Comparing 18 to 12 hours time groups, the W/D ratio 5.70±1.53 vs. 1.86±0.32, p=0.007 for control groups and 5.40±1.49 vs. 3.93±0.66, p=0.049 for colchicine groups were signifi cantly higher for both 12 h groups. Histology favored colchicine treated animals.
Conclusions: Colchicine in tested dose does not decrease edema after lung transplantation and does not improve lung function. 18 vs. 12 hours total ischemic graft storage time causes less lung edema.
Keywords: Colchicine, Ischemia reperfusion injury, Lung Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






